NCT05473624 Study of HRS-1167 as Monotherapy in Patients With Advanced Solid Tumors Status RECRUITING Phase PHASE1
NCT05470933 A Study Explore WJ01075 Tablets in Patients With Advanced Solid Tumors Status TERMINATED Phase PHASE1
NCT05469490 Safety of Navoximod and NLG802 With Stereotactic Body Radiotherapy (SBRT) Treatment of Advanced Solid Tumors Status WITHDRAWN Phase PHASE1
NCT05457517 A Phase 1b/2 Study of YL-13027 Combined With Sintilimab in Patients With Advanced Solid Tumors Status UNKNOWN Phase PHASE1/PHASE2
NCT05430555 A Phase 1/ 2, First-in-Human, Open-Label, Accelerated-Titration, Two-Part Clinical Trial of TK-8001 in Patients With HLA-A*02:01 Genotype and Advanced-Stage/ Metastatic MAGE-A1+ Solid Tumors Status TERMINATED Phase PHASE1/PHASE2
NCT05407675 A Study to Evaluate the Safety and Tolerability of BMS-986408 Alone and in Combination With Nivolumab or Nivolumab and Ipilimumab in Participants With Advanced Solid Tumors Status COMPLETED Phase PHASE1/PHASE2
NCT05394350 A Study of MK-1088 as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors (MK-1088-002) Status TERMINATED Phase PHASE1/PHASE2
NCT05393063 A Study to Evaluate the Efficacy and Safety of AK127 in Patients With Advanced Solid Tumors Status UNKNOWN Phase PHASE1
NCT05389462 A Study of Mipasetamab Uzoptirine (ADCT-601) in Participants With Solid Tumors Status TERMINATED Phase PHASE1
NCT05379985 Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS Status RECRUITING Phase PHASE1/PHASE2
NCT05378737 Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of BAT8006 for Injection Status COMPLETED Phase PHASE1
NCT05349409 A Trial of the Combination of SHR-A1811 and Fluzoparib in HER2-Expressing Cancers Status UNKNOWN Phase PHASE2
NCT05338346 A Study of ATG-018 (ATR Inhibitor) Treatment in Patients With Advanced Solid Tumors and Hematological Malignancies Status TERMINATED Phase PHASE1
NCT05320640 Study of Chidamide, Decitabine and Immune Checkpoint Inhibitors in R/R NHL and Advanced Solid Tumors Status UNKNOWN Phase PHASE1/PHASE2
NCT05287399 Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASC61in Subjects With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT05287165 Clinical Trial to Evaluate the Safety and Efficacy of IM96 CAR-T Cells Therapy in Patients With Advanced Digestive System Neoplasms Status UNKNOWN Phase EARLY_PHASE1
NCT05277168 A TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND EFFICACY OF SHR-A1904 IN SUBJECTS WITH ADVANCED SOLID TUMORS Status RECRUITING Phase PHASE1/PHASE2